BARMER GEK Arzneimittelreport 2013 - Presse

Wiesner G, Grimm J, Bittner E (1999b). Zum Herzinfarktgeschehen in der Bundesrepublik
Deutschland: Prävalenz, Inzidenz, Trend, Ost-West-Vergleich.
Gesundheitswesen 61 (Sonderheft 2): 72-78.
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ,
Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM,
Antman EM; TRITON-TIMI 38 Investigators (2007). Prasugrel versus clopidogrel
in patients with acute coronary syndromes. N Engl J Med 357(20): 2001-15.
Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009). Metaanalysis
of the impact of 9 medication classes on falls in elderly persons. Arch
Intern Med 169(21): 1952-60.
Yusuf S (2002). From the HOPE to the ONTARGET and the TRANSCEND studies:
challenges in improving prognosis. Am J Cardiol 89(2A): 18A-25A.
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001). Clopidogrel in
Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of
clopidogrel in addition to aspirin in patients with acute coronary syndromes
without ST-segment elevation. N Engl J Med 345(7): 494-502. Erratum in: N Engl
J Med (2001) 345(20): 1506. & N Engl J Med (2001) 345(23): 1716.
Zink A, Minden K, List SM (2010). Gesundheitsberichterstattung des Bundes; Band 49.
Entzündlich-rheumatische Erkrankungen. Berlin: Robert Koch-Institut.
Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske
G, Valluri SC (2008). A three-country comparison of psychotropic medication
prevalence in youth. Child and Adolescent Psychiatry and Mental Health 2(1):
26.
214